bYoRNA
French tech company | Builders Republic
About
Biotech developing a cheaper way to manufacture therapeutic mRNA inside living yeast cells rather than in a lab tube — enabling longer, more stable, less reactive RNA strands for cancer immunotherapies, gene editing and vaccines.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2022
- City
- PESSAC
- Region
- Nouvelle Aquitaine
- Tracked rounds
- 1
- Amount raised
- 1.5 M€ raised since 2020
Funding rounds
- Seed — 2025